Free Trial

Helius Medical Technologies Q1 2023 Earnings Report

Helius Medical Technologies logo
$0.91 +0.43 (+89.58%)
(As of 12/20/2024 05:45 PM ET)

Helius Medical Technologies Earnings Headlines

⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
Helius Medical Technologies (HSDT) Gets a Hold from Maxim Group
See More Helius Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Helius Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Helius Medical Technologies and other key companies, straight to your email.

About Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT), a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Helius Medical Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings